Navigation Links
Alexza Reports 2010 Fourth Quarter and Full Year Financial Results and Provides General Corporate Update
Date:3/15/2011

0;In 2010, these assumptions were influenced by the CRL received from the FDA, and the termination of the BLS agreements, both in October 2010, and the results of the December 2010 End-of-Review meeting with the FDA.

Alexza anticipates that with current cash, cash equivalents and marketable securities along with interest earned thereon, the proceeds from option exercises and purchases of common stock pursuant to its Employee Stock Purchase Plan, it will be able to maintain its current operations into the third quarter of 2011.  Changing circumstances may cause Alexza to consume capital significantly faster or slower than currently anticipated, or to alter its operations.

Conference Call Information

To access the conference call via the Internet, go to www.alexza.com, under the "Investor Relations" link.  Please join the call at least 15 minutes prior to the start of the call to ensure time for any software downloads that may be required.  Interested parties may also pre-register to avoid pre-call delays at https://www.theconferencingservice.com/prereg/key.process?key=P8XHWM67Y.  A replay of the call will be available for two weeks following the event.  

To access the live conference call via phone, dial 888-679-8035.  International callers may access the live call by dialing 617-213-4848.  The reference number to enter the call is 68027372.

The replay of the conference call may be accessed via the Internet, at www.alexza.com, or via phone at 888-286-8010 for domestic callers or 617-801-6888 for international callers.  The reference number for the replay of the call is 17789684.

About Alexza Pharmaceuticals, Inc.

Alexza is a pharmaceutical company focused on the research, development and commercialization of
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Alexza to Announce 2010 Year-End Financial Results on Tuesday, March 15, 2011
2. Alexza Pharmaceuticals Completes End-of-Review Meeting With FDA for AZ-004 (Staccato® Loxapine) NDA
3. Alexza Pharmaceuticals Provides Regulatory Update for AZ-004 (Staccato® Loxapine)
4. Alexza Pharmaceuticals Reports 2010 Third Quarter Financial Results and Provides Business Update
5. Alexza Pharmaceuticals to Announce 2010 Third Quarter Financial Results on November 9, 2010
6. Alexza Pharmaceuticals Reacquires U.S. and Canadian Rights for AZ-004 (Staccato® Loxapine)
7. Valeant Pharmaceuticals Announces That Alexza Pharmaceuticals Has Received a Complete Response Letter for AZ-004 (Staccato® Loxapine) Inhalation Aerosol NDA
8. Alexza Pharmaceuticals Receives Complete Response Letter for AZ-004 (Staccato® Loxapine) NDA
9. Alexzas Staccato® Nicotine Licensed to Cypress Bioscience
10. Alexza Pharmaceuticals to Present at Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference
11. Alexza Pharmaceuticals Appoints Joseph L. Turner to Its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... 31, 2015   BioLife Solutions , Inc. ... and marketer of proprietary clinical grade cell and ... freeze media and a related cloud ... smart shippers ("BioLife" or the "Company"), ... advanced biopharmaceutical company focused on developing and commercializing ...
(Date:8/30/2015)... 30, 2015 La solución ... l cuidado al paciente a ... Royal Philips  (NYSE: PHG, AEX: ... IntelliSpace Cardiovascular , un sistema web de gestión de ... analizar y compartir imágenes cardiovasculares e información en cualquier ...
(Date:8/28/2015)... , Aug. 28, 2015  Delays in the ... can slow down the decision-making process, resulting in ... absolutely critical for biopharmaceutical companies to develop a ... process for quicker and more meaningful insights. ... Practices, LLC, nearly three-quarters of benchmarked study participants ...
Breaking Medicine Technology:BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 2BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 3BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 4BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 5Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 2Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 3Expediting the Pharmaceutical Market Research Process for Faster Insights 2
... April 21, 2011 Marinus Pharmaceuticals, Inc., the ... nervous system disorders, today announced commencement of a ... for the treatment of posttraumatic stress disorder (PTSD). ... specific neurosteroid recognition site. Neurosteroid levels have been ...
... 21, 2011 Reportlinker.com announces that a new ... Body Contouring Devices - Global ... 2017 http://www.reportlinker.com/p0484508/Body-Contouring-Devices---Global-Pipeline-Analysis-Competitive-Landscape-and-Market-Forecasts-to-2017.html ... Competitive Landscape and Market Forecasts to 2017 ...
Cached Medicine Technology:Marinus Pharmaceuticals Announces Commencement of Phase 2 Trial of Ganaxolone for the Treatment of Posttraumatic Stress Disorder 2Marinus Pharmaceuticals Announces Commencement of Phase 2 Trial of Ganaxolone for the Treatment of Posttraumatic Stress Disorder 3Reportlinker Adds Body Contouring Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 2Reportlinker Adds Body Contouring Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 3Reportlinker Adds Body Contouring Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 4Reportlinker Adds Body Contouring Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 5Reportlinker Adds Body Contouring Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 6Reportlinker Adds Body Contouring Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 7Reportlinker Adds Body Contouring Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 8Reportlinker Adds Body Contouring Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 9Reportlinker Adds Body Contouring Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 10Reportlinker Adds Body Contouring Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 11Reportlinker Adds Body Contouring Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 12
(Date:8/31/2015)... ... 31, 2015 , ... Wound Care Advantage, a leader in ... to Hyperbaric Medicine Course. The next UHMS approved 40-hour Introduction to Hyperbaric Medicine ... Long Beach, CA. The meeting is open for registration from physicians, clinicians and ...
(Date:8/31/2015)... Dayton, Ohio (PRWEB) , ... August 31, 2015 ... ... Jenny Michael as Vice President, Marketing and Corporate Communications. In this capacity, Michael ... , CareSource is an industry leader in consumer-focused programs that have contributed ...
(Date:8/31/2015)... ... August 31, 2015 , ... In an article published August 24th ... Global Open Journal that discusses the future of 3-D printing technology as it relates ... customized implants, prosthetics, and other 3-D printed tools could be used to aid in ...
(Date:8/31/2015)... ... August 31, 2015 , ... NJ Top Docs Presents, Dr. Michael Betsy! Dr. ... Park Ridge, New Jersey, Dr. Michael Betsy graduated from Don Bosco Prep in 1990 and ... as team captain in both sports in his senior year. He was inducted into ...
(Date:8/31/2015)... ... , ... According to an article published August 3rd on Healio, ... underwent bariatric surgery “felt significantly better two years after surgery.” The article goes on ... study felt that their “mental health had been normalized” at the point when the ...
Breaking Medicine News(10 mins):Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 2Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 3Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 4Health News:CareSource Names Vice President, Marketing and Corporate Communications 2Health News:Recent Article on 3-D Printing Highlights the Future of Custom Medical Solutions Using the Technology, says Beverly Hills Physicians 2Health News:Recent Article on 3-D Printing Highlights the Future of Custom Medical Solutions Using the Technology, says Beverly Hills Physicians 3Health News:NJ Top Docs Presents, Dr. Michael Betsy! 2Health News:NJ Top Docs Presents, Dr. Michael Betsy! 3Health News:Article on Adolescent Bariatric Surgery Demonstrates the Powerful Effect of Being in Control, Notes Dr. Michael Feiz 2Health News:Article on Adolescent Bariatric Surgery Demonstrates the Powerful Effect of Being in Control, Notes Dr. Michael Feiz 3
... American Pacific,Corporation (Nasdaq: APFC ) today announced that ... on Thursday, February 7, 2008. John R.,Gibson, Chairman and ... to review the financial results and outlook of the,Company., ... 2008 at 1:30 p.m.,PST. To access the call please ...
... 1 The Chrysler Foundation and,Kenosha (Wis.) Engine Plant ... its new Aquatics Center., Chrysler,s donation will help ... to the YMCA. The center will have two pools: ... The YMCA will break,ground for the aquatic center later ...
... AMES, Iowa An anti-virus drug attacks influenza A by ... for the virus to infect healthy cells, according to a ... , Mei Hong, Iowa States John D. Corbett Professor in ... studying the effects of the antiviral drug amantadine on influenza ...
... Chiltern, the global contract research,organization, announced today that ... a leading Phase 1 unit located at Ninewells,Hospital and ... Kingdom,s major teaching hospitals. The purchase of DDS supplements,Chiltern,s ... was founded in 1982 and has completed more than ...
... and marital status underpin findings of 17-nation study ... factors for suicidal thoughts, plans and attempts are similar ... study, which used data collected by the World Health ... in 17 nations and found that an overall average ...
... succeeded in losing weight in a year-long medically supervised ... increase over that period, say researchers from The Children,s ... is a critical period for bone health in later ... the journal Obesity studied 62 adolescents between the ages ...
Cached Medicine News:Health News:American Pacific to Release Financial Results and Hold Fiscal 2008 First Quarter Investor Teleconference 2Health News:The Chrysler Foundation and Kenosha Engine Plant Donate $100,000 to New YMCA Aquatics Center 2Health News:Iowa State chemists track how drug changes, blocks flu virus 2Health News:Chiltern Announced Today That it has Acquired the Business of Drug Development Solutions (DDS) 2Health News:Chiltern Announced Today That it has Acquired the Business of Drug Development Solutions (DDS) 3Health News:Key Risk Factors for Suicide Consistent Across Globe 2Health News:Bone mineral content continues to increase in obese adolescents during weight loss 2
The Natural Selection family of specialty allografts is spinal concepts response to surgeon requests for spinal allograft devices to eliminate the need for painful autograft harvesting....
Transcranial vascular DWL doppler....
Transcranial vascular DWL doppler....
... Neurocare is a full-featured physiologic testing system offered ... contains many of the features of our flagship ... economical price. , ,The smaller size of the ... environment, the physician's office, a mobile service or ...
Medicine Products: